One of the most highly anticipated physicals in Mets franchise history happened Thursday in New York.

Carlos Correa was set to undergo a physical evaluation with the Mets on Thursday, his agent Scott Boras said, which if it came back clean enough for the club’s liking would finalize the 12-year, $315 million deal the two sides agreed to early Wednesday morning.

Correa’s physical with the Giants is where his 13-year, $350 million agreement hit a snag because of a “difference of opinion,” allowing the Mets to swoop in and come to terms with the star infielder. But Boras said he does not foresee any issues this time around and expects the deal to become official by Christmas, after the Mets take 24-48 hours to review the medical information.

“There is no current issue with Carlos’ health whatsoever,” Boras said Thursday at Yankee Stadium, where another one of his clients, Carlos Rodon, was introduced. “There’s been a lot of discussion about backs and ankles. There’s nothing about him that is currently any form of a medical issue.

“All the conjecture and evaluation of him has been about physicians using their crystal ball for years to come.”

Boras noted that three teams who had access to Correa’s medicals — “comprehensive medical records” and imaging provided by Boras’ team — each offered him contracts “in excess of 10 years.” Correa was also examined by Christopher Camp, the Twins team doctor and an orthopedic surgeon from the Mayo Clinic in Minnesota after the season, according to Boras, and received a “recommendation for over a 10-year contract.”

Still, the Giants’ deal with Correa fell apart this week because of a reported concern over his lower right leg — an injury that happened in the minors in 2014 when Correa broke his fibula and required surgery after sliding into a base. They were worried about the long-term stability of the leg, ESPN reported Thursday, and whether Correa’s mobility might diminish because of it. Other than the Giants’ trepidation, there has been little to suggest the injury has impacted Correa across eight seasons in the major leagues since then.

“I don’t know what the Giants were concerned about, because I never asked,” Boras said. “They just kept saying they needed additional time. For our [perspective], there is no medical issue with Carlos. There is none. So it had to be something that they felt was historical.

“The fact that everyone in this process was always willing to contract and negotiate with him meant that he was healthy, because no team is going to contract and continue to negotiate [if he was not].”

Correa’s only injured list stints over the last three years were for COVID and a contused middle finger after being hit by a pitch.

Once it was clear the Giants were not going to execute their letter of agreement with Correa, Boras re-engaged Mets owner Steve Cohen and GM Billy Eppler. The Mets initially balked at Boras’ asking price of 12 years and an average annual value of around $26.9 million (the AAV the Giants had offered), according to ESPN. But Cohen’s wife Alex, who is of Puerto Rican descent like Correa, pushed for signing the star infielder, per ESPN, and Cohen eventually added an extra million dollars a year to get the deal done.

Assuming he passes his physical with the Mets without issue, Correa is set to move from shortstop to third base, playing alongside his good friend Francisco Lindor. Boras, whom Correa tackled onto a bed in their San Francisco hotel once the deal was secured, said his client would embrace the position switch.

“Carlos has been very open in all of our discussions with teams in meetings that he views third base as a favorable place to play,” Boras said. “He likes to hit, and he feels he can get a little bit stronger and seize that position. He really enjoys playing it. I know a lot of shortstops like to stay at that position. Carlos was very open to it and informed every team, ‘I’ll move to third now, or I’ll play shortstop for you in the short term. However you determine you want to use me, I’m open to it.’ ”